First Step in Improving Function of CIs through
Biological Process
Editor: One of the things that the cochlear implant (CI)
manufacturers were talking about at the recent ALDAcon was a process
that encourages nerve tissue to grow close to CI electrodes. Doing so
would improve CI performance and reduce power requirements. Here's a
report on an encouraging university investigation into that technology.
~~~~~~~~~~~~~~~~~~~
Newswise - Since the first cochlear implants were inserted in the
late 1970's, they have revolutionized treatment for the nearly 23,000
severely hearing impaired Americans who have received the devices.
Science has yet to mimic the complex mechanism of the human ear as it
responds to sound, or compensate for the natural differences of the
human body, but researchers in the US and Germany are working together
to improve the function of cochlear implants using the body's own cells.
A cochlear implant is an electronic device designed for people with
severe to profound hearing loss who can derive little or no benefit from
hearing aids. The device cannot restore hearing; it allows the user to
hear sounds, which must then be interpreted into speech. The cochlear
implant consists of a sound processor with electrodes that are
surgically attached to the cochlea (part of the inner ear). When turned
on, the sound processor translates sound into electrical signals, which
are transferred to electrodes that stimulate the hearing nerve, which
sends information to the brain so it can interpret sound. In recent
years, technological advancements in cochlear implants have expanded the
number of information channels available to about ten, a vast
improvement in the ability to translate sound. However, compare those
ten channels to the thousands of channels a normal hearing cochlea uses
and the limitations of current technology becomes clear.
Based on the knowledge that more information channels will increase
the effectiveness of cochlear implants, researchers have set out to
develop a biological strategy to entice spiral ganglion neurons and
dendrites (tiny parts of the hearing nerve system) to grow very close to
the electrodes of a cochlear implant. If successful, this strategy might
allow the body's own cells to create hundreds of information channels,
dramatically improving the function of cochlear implants.
The first step of this effort, a study with animal cells, was
undertaken by Allen Ryan, and Lina Mullen, Kwang Pak, and John Wittig,
Joanna Xie, of the University of California San Diego School of Medicine
in La Jolla, Dominik Brors and Christof Aletsee of the University of
Wurzburg, and Stefan Dazert of Ruhr-University Bochum, Germany. The
results of their work, "Regrowth of Spiral Ganglion Neurites to a
Cochlear Implant," will be presented at the Mid Winter Meeting of
the Association for Research in Otolaryngology (www.aro.org) being held
February 22-26, 2004 at the Adam's Mark Hotel, Daytona Beach, FL.
Methodology: Spiral ganglion (SG) explants (each containing 50 to 100
neurons) were dissected from rodents and allowed to grow in various
mediums; some including growth factors. Neurites were measured
throughout the study by computer analysis to determine length, degree,
and direction of growth. Various forms of statistical analysis were used
to analyze the resulting data. The following were investigated:
a. The effects of growth factors on neurite extension from SG explants.
b. The role of extracellular matrix molecules in SG neuritis extension.
c. Eph/ephrin signaling (a large class of cell proteins whose signaling
plays an important role in neurite pathfinding in the brain).
d. Growth of SG neurites in three-dimensional cultures. (Neurites need a
structure on which to grow.)
e. Microchambers for evaluation of neurite responses to competing
signals.
f. Interaction of SG neurites with hair cells of the inner ear.
g. Response of SG neurites to cochlear implant materials.
Results: The concentration level of a variety of growth factors was
found to be key in the successful enhancement of neurite growth. Certain
extracellular matrices increased neurite length and some induced a turn
in direction of growth, but the number of neurites was not affected by
the matrices. Eph/ephrin signaling provides directional input to SG
neurites through negative influence. SG neurites prefer a structure on
which they can grow; a collagen gel was successful in providing a
suitable growth structure. Channel networks (microchambers) proved
successful at directing SG neurites toward a particular target. SG
neurites were shown to grow toward inner ear hair cells and make contact
with them. Interestingly, it was found that the materials and design of
a cochlear implant could be used to influence neurite growth.
Specifically, titanium strongly encouraged growth of neurites, which
were more likely to form on electrodes mounted flush to the implant.
Conclusion: This study provides evidence that targeted (toward the
cochlear implant) regrowth of spiral ganglion cells in the inner ear may
be possible; representing the first step in determining whether the
body's own growth mechanisms can be enlisted to improve cochlear implant
functionality. These results may also influence future material and
design of cochlear implants. Further investigation is needed to define
how spiral ganglion regrowth might be best achieved and the extent of
benefit from this strategy.